ADL BioPharma
João Paulo Cherubim is an experienced operations leader with a substantial background in the biotechnology and pharmaceutical sectors. Currently serving as Head of Operations at ADL BioPharma since January 2021, João Paulo has successfully turned around the company's EBITDA from negative to a profit of 5 million by the end of 2022. Prior to this role, João Paulo held various positions at Amyris Inc from 2011 to 2020, culminating as CMO Director Europe and leading significant production initiatives in Spain and Italy. With earlier roles including Plant Manager and Production Manager, João Paulo has developed expertise in production scaling, process development, and operations management. Academic qualifications include a Master's degree in Chemical Engineering from Universidade Estadual de Campinas and additional degrees in beverage technology and management from various institutions.
This person is not in any teams
This person is not in any offices
ADL BioPharma
ADL BioPharma’s experience in a leading position in the biopharmaceutical industry spans 6 decades. The company’s activity is mostly centred on two pivots: the development and production of active therapeutic substances (mainly beta-lactam active ingredients), and the development and manufacture on contract of products and intermediates obtained from fermentation processes for third parties in the food, cosmetic and biotechnology industries. What we offer The R&D, Quality and Production Units at ADL BioPharma offer comprehensive support for our customer’s projects, from the development of the process to its industrial scaling up, complying, upon demand, with the requirements established by the Good Manufacturing Practice system (GMP). We carry out projects that go from minimum amounts measured in grams to several tons, providing technical support throughout and in strict compliance with the applicable regulations.